Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
Nicolas VuilleumierLeonilde BonfrateMirco VaccaMaria De AngelisIlaria FarellaElisa LanzaMohamad KhalilDavid Q-H WangMarkus SperandioAgostino Di CiaulaPublished in: International journal of molecular sciences (2022)
Gut microbiota encompasses a wide variety of commensal microorganisms consisting of trillions of bacteria, fungi, and viruses. This microbial population coexists in symbiosis with the host, and related metabolites have profound effects on human health. In this respect, gut microbiota plays a pivotal role in the regulation of metabolic, endocrine, and immune functions. Bacterial metabolites include the short chain fatty acids (SCFAs) acetate (C2), propionate (C3), and butyrate (C4), which are the most abundant SCFAs in the human body and the most abundant anions in the colon. SCFAs are made from fermentation of dietary fiber and resistant starch in the gut. They modulate several metabolic pathways and are involved in obesity, insulin resistance, and type 2 diabetes. Thus, diet might influence gut microbiota composition and activity, SCFAs production, and metabolic effects. In this narrative review, we discuss the relevant research focusing on the relationship between gut microbiota, SCFAs, and glucose metabolism.
Keyphrases
- insulin resistance
- type diabetes
- fatty acid
- human health
- metabolic syndrome
- risk assessment
- ms ms
- endothelial cells
- weight loss
- adipose tissue
- skeletal muscle
- physical activity
- high fat diet induced
- high fat diet
- microbial community
- autism spectrum disorder
- polycystic ovary syndrome
- weight gain
- body mass index
- intellectual disability